The synergistic effects of DNA-targeted chemotherapeutics and histone deacetylase inhibitors as therapeutic strategies for cancer treatment. (Q38017232)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22680633%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

The synergistic effects of DNA-targeted chemotherapeutics and histone deacetylase inhibitors as therapeutic strategies for cancer treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22680633%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22680633%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

René Kizek

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22680633%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

M Stiborová

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22680633%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

T Eckschlager

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22680633%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

J Hraběta

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22680633%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

V Adam

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22680633%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

E Frei

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22680633%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

1 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22680633%20AND%20SRC:MED&resulttype=core&format=json

Current Medicinal Chemistry

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22680633%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22680633%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22680633%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

4218-4238

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22680633%20AND%20SRC:MED&resulttype=core&format=json

Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation.

4 February 2020

cites work

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1158/0008-5472.CAN-06-3996

Carfilzomib interacts synergistically with histone deacetylase inhibitors in mantle cell lymphoma cells in vitro and in vivo

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1158/1535-7163.MCT-10-1108

The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1182/BLOOD-2009-12-257261

Identifiers

DOI

10.2174/092986712802884286

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22680633%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference